Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Allergen Type (Inhaled, Drug), By End Use, By Diagnostic Test, By Drug Class, And Segment Forecasts, 2019 - 2026

Published: Jun, 2019 | Pages: 100 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global allergy diagnostics and therapeutics market size is expected to reach USD 51.95 billion by 2026 registering a CAGR of 6.3%, according to a new study by Grand View Research, Inc. Increasing prevalence of allergic conditions coupled with adoption of immunoassay as diagnostic test is expected to serve this market with lucrative growth opportunities. According to the report published by the World Allergy Journal in May 2014, around 300 million cases of asthma and 200 to 250 million cases of food allergies were reported. This number is expected to increase over the forecast period due to sedentary lifestyle and poor dietary habits.

Rising industrial pollution, rapid urbanization in developing countries, and increasing Greenhouse Gas (GHG) concentrations are expected to result in increased prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period. Emergence of technologically advanced products, such as MeDALL allergen-chip for allergy determination, is further expected to propel the market growth in the years to come.

The global market is highly competitive and is led by companies including Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical, and Hitachi Chemical Diagnostics. Most of the industry participants focus on the development of advanced products and technologies to gain competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan, which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy.

Further key findings from the study suggest:

• Instruments product segment is anticipated to witness the highest CAGR of 12.2% from 2019 to 2025 due to high demand for analyzers and laminators for allergy diagnostics

• In vitro is expected to be the largest as well as fastest-growing test segment over the estimated period on account of rising demand for minimally invasive and allergen-specific tests

• Antihistamines drug class led the allergy diagnostics and therapeutics market in 2018 due to its advantages, such as non sedating nature and minimum side effects with use of second generation antihistamines in allergy treatment

• Immunotherapy vaccines is expected to register the maximum CAGR from 2019 to 2025 owing to extensive R&D in the field and advent of sublingual immunotherapy tablets in the treatment of allergic rhinitis

• For instance, in April 2014, the U.S. FDA approved a five-grass pollen sublingual tablet (Ex-Oralair) by Stallergenes, which is used in the treatment of pollen allergy

 Table of Contents

Chapter 1 Research Methodology & Scope
                  1.1 Market Segmentation & Scope
                      1.1.1 Estimates and Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased database:
                      1.3.2 GVR's Internal Database
                      1.3.3 Secondary sources
                      1.3.4 Primary Research:
                      1.3.5 Details of Primary Research
                          1.3.5.1 Data for primary interviews in North america
                          1.3.5.2 Data for primary interviews in Europe
                          1.3.5.3 Data for primary interviews in Asia Pacific
                          1.3.5.4 Data for primary interviews in Middle East and Africa
                  1.4 Information or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis (Model 1)
                          1.6.1.1 Approach 1: Commodity Flow Approach
                  1.7 List of Secondary Sources
                  1.8 List of Primary Sources
                  1.9 Report Objectives
Chapter 2 Executive Summary
                  2.1 Market Outlook
                      2.1.1 Allergy Diagnostics & Therapeutics market Outlook, 2014 - 2026 (USD Million)
                  2.2 Segment Outlook
                  2.3 Competitive Outlook
                  2.4 Allergy Diagnostics & Therapeutics Market Summary, 2018
Chapter 3 Allergy Diagnostics & Therapeutics Market Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent market analysis
                      3.1.2 Ancillary market Analysis
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Technology Timeline Overview
                      3.3.1 Technology Timeline Allergy Diagnostics & Therapeutics changing technology & adoption
                  3.4 Regulatory Framework
                      3.4.1 List of regulatory bodies
                  3.5 Allergy Diagnostics & Therapeutics Market Dynamics
                      3.5.1 Market driver analysis
                          3.5.1.1 Increasing incidences of allergy diseases
                          3.5.1.2 Increasing demand for IVD tests for allergy diagnosis
                          3.5.1.3 Introduction of technologically advance allergy diagnostics products
                          3.5.1.4 Growing healthcare expenditure triggering development of effective allergy diagnostic & therapeutic products
                      3.5.2 Market restraint analysis
                          3.5.2.1 Low adoption and penetration in developing countries due to high cost of technology
                          3.5.2.2 Presence of ambiguous regulatory framework
                  3.6 Allergy Diagnostics & Therapeutics Market Analysis Tools: Porters
                      3.6.1 Supplier Power
                      3.6.2 Buyer Power
                      3.6.3 Threat of substitutes
                      3.6.4 Threat of new entrants
                      3.6.5 Competitive Rivalary
                  3.7 PESTEL Analysis
                      3.7.1 Political Landscape
                      3.7.2 Economic Landscape
                      3.7.3 Technology Landscape
                      3.7.4 Technology Landscape
                      3.7.5 Social Landscape
                  3.8 Major Deals & Strategic Alliances Analysis
                      3.8.1 Mergers & Acquisitions
                      3.8.2 Product launch
                      3.8.3 Expansion
                      3.8.4 Partnership & Collaborations
                      3.8.5 Market Entry Strategies
Chapter 4 Allergy Diagnostics & Therapeutics Market: Competitive Analysis
                  4.1 Market Participation Categorization
                  4.2 Public Companies
                      4.2.1 Company market position analysis
                      4.2.2 Competitive Dashboard Analysis
                          4.2.2.1 Market Differentiators
                      4.2.3 Company Market Share
                      4.2.4 Competitive Dashboard Analysis
                  4.3 Private Companies
                      4.3.1 List of key emerging companies
Chapter 5 Allergy Diagnostics Market: Product Estimates & Trend Analysis
                  5.1 Product Market Share Analysis, 2018 & 2026
                  5.2 Product Dashboard
                      5.2.1 Instruments
                          5.2.1.1 Instruments market estimates and forecasts, 2014 - 2026 (USD Million)
                      5.2.2 Consumables
                          5.2.2.1 Consumables market estimates and forecasts, 2014 - 2026 (USD Million)
                      5.2.3 Services
                          5.2.3.1 Services market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 6 Allergy Diagnostics Market: Allergen Type Estimates & Trend Analysis
                  6.1 Allergen type Market Share Analysis, 2018 & 2026
                  6.2 Allergen type Dashboard
                  6.3 Food
                      6.3.1 Food market estimates and forecasts, 2014 - 2026 (USD Million)
                  6.4 Inhaled
                      6.4.1 Inhaled market estimates and forecasts, 2014 - 2026 (USD Million)
                  6.5 Drug
                      6.5.1 Drug drugs market estimates and forecasts, 2014 - 2026 (USD Million)
                  6.6 Others
                      6.6.1 Others market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 7 Allergy Diagnostics Market: End Use Estimates & Trend Analysis
                  7.1 End-use Market Share Analysis, 2018 & 2026
                  7.2 End-use Dashboard
                  7.3 Diagnostics labs
                      7.3.1 Diagnostics labs market estimates and forecasts, 2014 - 2026 (USD Million)
                  7.4 Hospitals
                      7.4.1 Hospitals market estimates and forecasts, 2014 - 2026 (USD Million)
                  7.5 Academic research institutes
                      7.5.1 Academic research institutes market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 8 Allergy Diagnostics Market: Diagnostic Tests Estimates & Trend Analysis
                  8.1 Diagnostic tests Market Share Analysis, 2018 & 2026
                  8.2 Diagnostic tests Dashboard
                  8.3 In vivo
                      8.3.1 In vivo market estimates and forecasts, 2014 - 2026 (USD Million)
                      8.3.2 Skin prick test
                          8.3.2.1 Skin prick test market estimates and forecasts, 2014 - 2026 (USD Million)
                      8.3.3 Intradermal
                          8.3.3.1 Intradermal market estimates and forecasts, 2014 - 2026 (USD Million)
                      8.3.4 Patch test
                          8.3.4.1 Patch test market estimates and forecasts, 2014 - 2026 (USD Million)
                  8.4 In vitro
                      8.4.1 In vitro market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 9 Allergy Therapeutics Market: Drug Class Estimates & Trend Analysis
                  9.1 Drug class Market Share Analysis, 2018 & 2026
                  9.2 Drug class Dashboard
                  9.3 Antihistamines
                      9.3.1 Antihistamines market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.4 Decongestants
                      9.4.1 Decongestants market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.5 Corticosteroids
                      9.5.1 Corticosteroids market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.6 Mast cell stabilizers
                      9.6.1 Mast cell stabilizers market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.7 Leukotriene Inhibitors
                      9.7.1 Leukotriene Inhibitors market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.8 Nasal anticholinergics
                      9.8.1 Nasal anticholinergics market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.9 Immunomodulators
                      9.9.1 Immunomodulators market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.10 Autoinjectable Epinephrine
                      9.10.1 Autoinjectable Epinephrine market estimates and forecasts, 2014 - 2026 (USD Million)
                  9.11 Immunotherapy
                      9.11.1 Immunotherapy market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 10 Allergy Diagnostics & Therapeutics Market: Regional Estimates & Trend Analysis, By, Product, Allergen type, End Use, Diagnostic tests, Drug class Component, And End-Use
                  10.1 Regional Market Snapshot
                  10.2 Market Share Analysis by Country, 2018
                      10.2.1 North America
                      10.2.2 Europe
                      10.2.3 Asia Pacific
                      10.2.4 Latin America
                      10.2.5 MEA
                  10.3 North America
                      10.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.3.2 U.S.
                          10.3.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.3.3 Canada
                          10.3.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                  10.4 Europe
                      10.4.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.4.2 U.K.
                          10.4.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.4.3 Germany
                          10.4.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                  10.5 Asia Pacific
                      10.5.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.5.2 Japan
                          10.5.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.5.3 China
                          10.5.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                  10.6 Latin America
                      10.6.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.6.2 Brazil
                          10.6.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                  10.7 MEA
                      10.7.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
                      10.7.2 South Africa
                          10.7.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 11 Company Profiles
                  11.1 bioMerieux
                      11.1.1 Company overview
                      11.1.2 Financial performance
                      11.1.3 Product benchmarking
                      11.1.4 Strategic initiatives
                  11.2 Danaher Corporation
                      11.2.1 Company overview
                      11.2.2 Product benchmarking
                      11.2.3 Strategic initiatives
                  11.3 Thermo Fisher Scientific
                      11.3.1 Company overview
                      11.3.2 Financial Performance
                      11.3.3 Product benchmarking
                      11.3.4 Strategic initiatives
                  11.4 Stallergenes Greer
                      11.4.1 Company overview
                      11.4.2 Financial Performance
                      11.4.3 Product benchmarking
                      11.4.4 Strategic initiatives
                  11.5 Hitachi Chemical Diagnostics
                      11.5.1 Company overview
                      11.5.2 Product benchmarking
                      11.5.3 Strategic initiatives
                  11.6 Siemens Healthcare
                      11.6.1 Company overview
                      11.6.2 Financial Performance
                      11.6.3 Product benchmarking
                      11.6.4 Strategic initiatives
                  11.7 Omega Diagnostics
                      11.7.1 Company overview
                      11.7.2 Product benchmarking
                  11.8 Hycor Biomedical
                      11.8.1 Company overview
                      11.8.2 Financial Performance
                      11.8.3 Product benchmarking
                      11.8.4 Strategic initiatives
                  11.9 Lincoln Diagnostics
                      11.9.1 Company overview
                      11.9.2 Financial performance
                      11.9.3 Product benchmarking
                      11.9.4 Strategic initiatives
                  11.10 HOB Biotech Group
                      11.10.1 Company overview
                      11.10.2 Financial performance
                      11.10.3 Product benchmarking
                      11.10.4 Strategic initiatives
                  11.11 Alcon Laboratories, Inc.
                      11.11.1 Company overview
                      11.11.2 Financial performance
                      11.11.3 Product benchmarking
                      11.11.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of key emerging companies
Table 3 Allergy Diagnostics - Industry Snapshot & Key Buying Criteria, 2014 - 2026
Table 4 Global allergy therapeutics and diagnostics market, 2012 - 2022(USD Million)
Table 5 Global allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 6 Global allergy diagnostics market, by allergen type, 2014 - 2026 (USD Million)
Table 7 Global allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 8 Global allergy diagnostics market, by type of test, 2014 - 2026 (USD Million)
Table 9 Global allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 10 Global allergy diagnostics market, by region, 2014 - 2026 (USD Million)
Table 11 Allergy Diagnostics - Key market restraint analysis
Table 12 Allergy Diagnostics - Pipeline Overview
Table 13 North America allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 14 North America allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 15 North America allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 16 North America allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 17 North America In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 18 North America allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 19 U.S. allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 20 U.S. allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 21 U.S. allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 22 U.S. allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 23 U.S. In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 24 U.S. allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 25 Canada allergy diagnostics market, by product, 2014- 2026 (USD Million)
Table 26 Canada allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 27 Canada allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 28 Canada allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 29 Canada In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 30 Canada allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 31 Europe allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 32 Europe diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 33 Europe allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 34 Europe allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 35 Europe In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 36 Europe allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 37 Germany allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 38 Germany allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 39 Germany allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 40 Germany allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 41 Germany In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 42 Germany allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 43 U.K. allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 44 U.K. allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 45 U.K. allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 46 U.K. allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 47 Asia Pacific allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 48 Asia Pacific allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 49 Asia Pacific allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 50 Asia Pacific allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 51 Asia Pacific In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 52 Asia Pacific allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 53 Japan allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 54 Japan allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 55 Japan allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 56 Japan allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 57 Japan In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 58 Japan allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 59 China allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 60 China allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 61 China allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 62 China allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 63 China In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 64 China allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 65 Latin America allergy diagnostics market, by product, 2014- 2026 (USD Million)
Table 66 Latin America allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 67 Latin America allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 68 Latin America allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 69 Latin America In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 70 Latin America allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 71 Brazil allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 72 Brazil allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 73 Brazil allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 74 Brazil allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 75 Brazil In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 76 Brazil allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 77 Mexico allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 78 Mexico allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 79 Mexico allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 80 Mexico allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 81 Mexico In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 82 Mexico allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 83 MEA allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 84 MEA allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 85 MEA allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 86 MEA allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 87 MEA In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 88 MEA allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 89 South Africa allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 90 South Africa allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 91 South Africa allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 92 South Africa allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 93 South Africa In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 94 South Africa allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)
Table 95 Saudi Arabia allergy diagnostics market, by product, 2014 - 2026 (USD Million)
Table 96 Saudi Arabia allergy diagnostics market, by type of allergens, 2014 - 2026 (USD Million)
Table 97 Saudi Arabia allergy diagnostics market, by end-use, 2014 - 2026 (USD Million)
Table 98 Saudi Arabia allergy diagnostics market, by test outlook, 2014 - 2026 (USD Million)
Table 99 Saudi Arabia In Vivo/ Skin market, by types, 2014 - 2026 (USD Million)
Table 100 Saudi Arabia allergy therapeutics market, by drug class, 2014 - 2026 (USD Million)

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Primary interviews in North America
Fig. 6 Primary interviews in Europe
Fig. 7 Primary interviews in Asia Pacific
Fig. 8 Primary interviews in Middle East and Africa
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Commodity flow analysis
Fig. 14 Allergy Diagnostics & Therapeutics market snapshot
Fig. 15 Penetration & growth prospect mapping
Fig. 16 Technology impact analysis
Fig. 17 Allergy diagnostics & therapeutics market dynamics
Fig. 18 Allergy diagnostics & therapeutics market driver impact
Fig. 19 Allergy diagnostics & therapeutics market restraint impact
Fig. 20 Strategy mapping
Fig. 21 Market participant categorization
Fig. 22 Company market position analysis
Fig. 23 Market differentiators
Fig. 24 Company market share analysis
Fig. 25 Competitive dashboard analysis
Fig. 26 Allergy diagnostics market: Product movement analysis
Fig. 27 Allergy diagnostics market product dashboard
Fig. 28 Global instruments market, 2014 - 2026 (USD Million)
Fig. 29 Global consumables market, 2014 - 2026 (USD Million)
Fig. 30 Global services market, 2014 - 2026 (USD Million)
Fig. 31 Allergy diagnostics market: allergen type movement analysis
Fig. 32 Allergy diagnostics allergen type dashboard
Fig. 33 Global food market, 2014 - 2026 (USD Million)
Fig. 34 Global inhaled market, 2014 - 2026 (USD Million)
Fig. 35 Global drug drugs market, 2014 - 2026 (USD Million)
Fig. 36 Global others market, 2014 - 2026 (USD Million)
Fig. 37 Allergy diagnostics market: End-use movement analysis
Fig. 38 Allergy diagnostics End-use dashboard
Fig. 39 Global diagnostics labs market, 2014 - 2026 (USD Million)
Fig. 40 Global hospitals market, 2014 - 2026 (USD Million)
Fig. 41 Global Academic research institutes market, 2014 - 2026 (USD Million)
Fig. 42 Allergy diagnostics market: Diagnostic tests movement analysis
Fig. 43 Allergy diagnostic tests dashboard
Fig. 44 Global in vivo market, 2014 - 2026 (USD Million)
Fig. 45 Global skin prick test market, 2014 - 2026 (USD Million)
Fig. 46 Global intradermal market, 2014 - 2026 (USD Million)
Fig. 47 Global patch test market, 2014 - 2026 (USD Million)
Fig. 48 Global in vitro market, 2014 - 2026 (USD Million)
Fig. 49 Allergy therapeutics market: Drug class movement analysis
Fig. 50 Allergy therapeutics Drug class dashboard
Fig. 51 Global antihistamines market, 2014 - 2026 (USD Million)
Fig. 52 Global decongestants market, 2014 - 2026 (USD Million)
Fig. 53 Global corticosteroids market, 2014 - 2026 (USD Million)
Fig. 54 Global mast cell stabilizers market, 2014 - 2026 (USD Million)
Fig. 55 Global leukotriene Inhibitors market, 2014 - 2026 (USD Million)
Fig. 56 Global nasal anticholinergics market, 2014 - 2026 (USD Million)
Fig. 57 Global immunomodulators market, 2014 - 2026 (USD Million)
Fig. 58 Global autoinjectable epinephrine market, 2014 - 2026 (USD Million)
Fig. 59 Global immunotherapy market, 2014 - 2026 (USD Million)
Fig. 60 Regional market place: Key takeaways
Fig. 61 North America allergy diagnostics & therapeutics market share by countries, 2018
Fig. 62 Europe allergy diagnostics & therapeutics market share by countries, 2018
Fig. 63 Asia Pacific allergy diagnostics & therapeutics market share by countries, 2018
Fig. 64 Latin America allergy diagnostics & therapeutics market share by countries, 2018
Fig. 65 MEA allergy diagnostics & therapeutics market share by countries, 2018
Fig. 66 Regional outlook, 2018 & 2026
Fig. 67 North America allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 68 U.S. allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 69 Canada allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 70 Europe allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 71 U.K. allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 72 Germany allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 73 Asia Pacific allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 74 Japan allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 75 China allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 76 Latin America allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 77 Brazil allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 78 MEA allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)
Fig. 79 South Africa allergy diagnostics & therapeutics market, 2014 - 2026 (USD Million)